Testing effectiveness (Phase 2)Study completedNCT04710641
What this trial is testing
Radomised Phase II Study of MTL-CEBPA Plus Sorafenib or Sorafenib Alone
Who this might be right for
Hepatocellular CarcinomaHepatitis BHepatitis C
Mina Alpha Limited 8